FibroGen, Inc (FGEN) financial statements (2022 and earlier)

Company profile

Business Address 409 ILLINOIS STREET
SAN FRANCISCO, CA 94158
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments405486507544 688
Cash and cash equivalents171275353434 532
Short-term investments234212154111 155
Receivables17362441 26
Inventory, net of allowances, customer advances and progress billings31292521 12
Inventory31292521 12
Prepaid expense77710 6
Other current assets5713 6
Other undisclosed current assets88 4  
Total current assets:474573564622 737
Noncurrent Assets
Finance lease, right-of-use asset11127 32
Operating lease, right-of-use asset919497   
Property, plant and equipment28293131 36
Long-term investments and receivables4310694 0
Long-term investments4310694 0
Restricted cash and investments22    
Other noncurrent assets6559 4
Other undisclosed noncurrent assets16814355 2
Total noncurrent assets:300277244166 75
TOTAL ASSETS:774851809787 812
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities19917519724 8
Accounts payable26244924 8
Accrued liabilities173151148   
Deferred revenue16232511 8
Debt00012 12
Due to related parties000   
Other undisclosed current liabilities111111120 91
Total current liabilities:225209233167 118
Noncurrent Liabilities
Long-term debt and lease obligation89919422 29
Finance lease, liability00022 29
Operating lease, liability899194   
Liabilities, other than long-term debt213187184190 176
Deferred revenue187162153151 138
Other liabilities26243138 38
Other undisclosed noncurrent liabilities18181818 19
Total noncurrent liabilities:319296296230 223
Total liabilities:545505529397 341
Stockholders' equity
Stockholders' equity attributable to parent209326261371 452
Common stock1111 1
Additional paid in capital1,4761,4591,4441,420 1,370
Accumulated other comprehensive loss(4)(4)(5)(5) (4)
Accumulated deficit(1,264)(1,130)(1,180)(1,046) (915)
Stockholders' equity attributable to noncontrolling interest20191919 19
Total stockholders' equity:229345280390 471
TOTAL LIABILITIES AND EQUITY:774851809787 812

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Revenues171562438 44
Cost of revenue(3)(3)    
Gross profit:131532438 44
Operating expenses(149)(102)(158)(109) (12)
Operating income (loss):(135)51(134)(70) 32
Nonoperating income (expense)1(1)    
Interest and debt expense(0)(0)(0)(1) (1)
Income (loss) from continuing operations before equity method investments, income taxes:(134)50(134)(71) 32
Income from equity method investments00    
Other undisclosed income (loss) from continuing operations before income taxes(1) (0)(0) 1
Income (loss) from continuing operations before income taxes:(135)50(135)(71) 33
Income tax expense (benefit)(0)(0)0(0) (0)
Income (loss) before gain (loss) on sale of properties:(135)50(135)(72) 33
Other undisclosed net income (loss)1  (0)  
Net income (loss):(134)50(135)(72) 33
Other undisclosed net income attributable to parent  1   
Net income (loss) available to common stockholders, diluted:(134)50(134)(72) 33

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Net income (loss):(134)50(135)(72) 33
Other comprehensive income (loss)(0)00(0) (3)
Comprehensive income (loss):(134)50(134)(72) 30
Other undisclosed comprehensive income, net of tax, attributable to parent  1   
Comprehensive income (loss), net of tax, attributable to parent:(134)50(134)(72) 30

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: